Results 1 to 10 of about 407,552 (296)

Intravenous immunoglobulin: Revisited – My experience

open access: yesIndian Journal of Dermatology, 2021
Background: Many a times while treating dermatoses conventional therapies are either contraindicated or not effective. Intravenous immunoglobulin (IVIG) is a good alternative available to tide over crises.
Sanjeev S Vaishampayan   +5 more
doaj   +3 more sources

Use of intravenous immunoglobulin in neonates with haemolytic disease and immune thrombocytopenia [PDF]

open access: yesVojnosanitetski Pregled, 2013
Background/Aim. Intravenous immunoglobulin is a blood product made of human polyclonal immunoglobulin G. The mode of action of intravenous immunoglobulin is very complex.
Marković-Sovtić Gordana   +4 more
doaj   +3 more sources

Clinical uses of intravenous immunoglobulin [PDF]

open access: yesClinical and Experimental Immunology, 2005
There has been a rapid expansion in the use of intravenous immunoglobulin (IVIG) for an ever growing number of conditions. It is a product with an excellent safety record without the side effects of steroids or other immunosuppressive agents. There have been numerous recent advances in our understanding of the mechanisms of action of IVIG in many of ...
Stephen Jolles
exaly   +3 more sources

Tocilizumab for the Treatment of Intravenous Immunoglobulin-Resistant Kawasaki Disease in Children: Two Case Reports and Literature Review [PDF]

open access: yesJournal of Inflammation Research
Li-E Wu, Chun-Lin Huang, Jun-Yu Wei, Si-Liang Lu Department of Pediatrics, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Guangxi Clinical Research Center for Pediatric Diseases, Nanning, Guangxi, 530000, People’s Republic of ...
Wu LE, Huang CL, Wei JY, Lu SL
doaj   +2 more sources

High-dose immunoglobulin-dependent chronic inflammatory demyelinating polyneuropathy successfully managed with subcutaneous immunoglobulin using pharmacokinetic analysis

open access: yeseNeurologicalSci, 2022
Immunoglobulin G therapy for chronic inflammatory demyelinating polyneuropathy (CIDP) often requires individual dose adjustments because of the heterogeneity of pathogenesis and varying catabolic rates.
Satomi Hiya   +4 more
doaj   +1 more source

Nephrotoxicity of intravenous immunoglobulin [PDF]

open access: yesQJM, 2000
Individual case reports have documented nephrotoxicity of intravenous immunoglobulin (IVIG) preparations, but the true incidence of renal dysfunction is unknown and many data sheets do not include renal impairment as a side-effect of these preparations.
J B, Levy, C D, Pusey
openaire   +2 more sources

Intravenous Immunoglobulin Therapy in Myocarditis

open access: yesIranian Journal of Allergy, Asthma and Immunology, 2020
Myocarditis is an inflammatory disease of the myocardium with lymphocyte infiltration and myocyte necrosis leading to a wide range of clinical presentations including heart failure, arrhythmia, and cardiogenic shock.
Amir Hossein Mansourabadi   +4 more
doaj   +1 more source

Intravenous Immunoglobulin Therapy for Critically Ill COVID-19 Patients With Different Inflammatory Phenotypes: A Multicenter, Retrospective Study

open access: yesFrontiers in Immunology, 2022
BackgroundThe benefits of intravenous immunoglobulin administration are controversial for critically ill COVID-19 patients.MethodsWe analyzed retrospectively the effects of immunoglobulin administration for critically ill COVID-19 patients.
Yan Chen   +24 more
doaj   +1 more source

Intravenous immunoglobulin induced pancytopenia while preventing development of gestational alloimmune liver disease: A case report

open access: yesCase Reports in Women's Health, 2022
Gestational alloimmune liver disease is a rare complication associated with reactive maternal immunoglobulins resulting in neonatal liver pathology. The mainstay treatment for prevention in future pregnancies is intravenous immunoglobulins.
Minhazur Sarker   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy